412 related articles for article (PubMed ID: 34134723)
1. Circulating tumor DNA tracking through driver mutations as a liquid biopsy-based biomarker for uveal melanoma.
Bustamante P; Tsering T; Coblentz J; Mastromonaco C; Abdouh M; Fonseca C; Proença RP; Blanchard N; Dugé CL; Andujar RAS; Youhnovska E; Burnier MN; Callejo SA; Burnier JV
J Exp Clin Cancer Res; 2021 Jun; 40(1):196. PubMed ID: 34134723
[TBL] [Abstract][Full Text] [Related]
2. Potential of Aqueous Humor as a Liquid Biopsy for Uveal Melanoma.
Im DH; Peng CC; Xu L; Kim ME; Ostrow D; Yellapantula V; Bootwalla M; Biegel JA; Gai X; Prabakar RK; Kuhn P; Hicks J; Berry JL
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682905
[TBL] [Abstract][Full Text] [Related]
3. Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy.
Soltysova A; Sedlackova T; Dvorska D; Jasek K; Chokhachi Baradaran P; Horvathova Kajabova V; Demkova L; Buocikova V; Kurucova T; Lyskova D; Furdova A; Minarik G; Babal P; Dankova Z; Smolkova B
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348918
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Circulating Tumor DNA as a Liquid Biomarker in Uveal Melanoma.
de Bruyn DP; van Poppelen NM; Brands T; van den Boom SC; Eikenboom E; Wagner A; van Veghel-Plandsoen MM; Geeven G; Beverloo B; van Rij CM; Verdijk RM; Naus NC; Bagger MM; Kiilgaard JF; de Klein A; Brosens E; Kiliç E
Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):11. PubMed ID: 38319670
[TBL] [Abstract][Full Text] [Related]
5. [Detection of
Zhao Q; Chen YY; Hou C; Zeng SX; Zhang YH; Zhang JJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 51(4):521-525. PubMed ID: 32691561
[TBL] [Abstract][Full Text] [Related]
6. Multiplex detection of ctDNA mutations in plasma of colorectal cancer patients by PCR/SERS assay.
Lyu N; Rajendran VK; Diefenbach RJ; Charles K; Clarke SJ; Engel A; ; Rizos H; Molloy MP; Wang Y
Nanotheranostics; 2020; 4(4):224-232. PubMed ID: 32923312
[TBL] [Abstract][Full Text] [Related]
7. Mutations of GNAQ, GNA11, SF3B1, EIF1AX, PLCB4 and CYSLTR in Uveal Melanoma in Chinese Patients.
Hou C; Xiao L; Ren X; Tang F; Guo B; Zeng W; Liang C; Yan N
Ophthalmic Res; 2020; 63(3):358-368. PubMed ID: 31614358
[TBL] [Abstract][Full Text] [Related]
8. Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma.
Beasley A; Isaacs T; Khattak MA; Freeman JB; Allcock R; Chen FK; Pereira MR; Yau K; Bentel J; Vermeulen T; Calapre L; Millward M; Ziman MR; Gray ES
JCO Precis Oncol; 2018; 2():. PubMed ID: 32913999
[TBL] [Abstract][Full Text] [Related]
9. Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma.
Metz CH; Scheulen M; Bornfeld N; Lohmann D; Zeschnigk M
Cancer Med; 2013 Apr; 2(2):208-15. PubMed ID: 23634288
[TBL] [Abstract][Full Text] [Related]
10. Future perspectives of uveal melanoma blood based biomarkers.
Beasley AB; Chen FK; Isaacs TW; Gray ES
Br J Cancer; 2022 Jun; 126(11):1511-1528. PubMed ID: 35190695
[TBL] [Abstract][Full Text] [Related]
11. Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients.
Tzanikou E; Haselmann V; Markou A; Duda A; Utikal J; Neumaier M; Lianidou ES
Clin Chem Lab Med; 2020 Oct; 58(11):1799-1807. PubMed ID: 31953992
[TBL] [Abstract][Full Text] [Related]
12. Early detection of metastatic uveal melanoma by the analysis of tumor-specific mutations in cell-free plasma DNA.
Le Guin CHD; Bornfeld N; Bechrakis NE; Jabbarli L; Richly H; Lohmann DR; Zeschnigk M
Cancer Med; 2021 Sep; 10(17):5974-5982. PubMed ID: 34291585
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy-based analysis by ddPCR and CAPP-Seq in melanoma patients.
Kaneko A; Kanemaru H; Kajihara I; Mijiddorj T; Miyauchi H; Kuriyama H; Kimura T; Sawamura S; Makino K; Miyashita A; Aoi J; Makino T; Masuguchi S; Fukushima S; Ihn H
J Dermatol Sci; 2021 Jun; 102(3):158-166. PubMed ID: 34049769
[TBL] [Abstract][Full Text] [Related]
14. Detection of metastases using circulating tumour DNA in uveal melanoma.
Beasley AB; de Bruyn DP; Calapre L; Al-Ogaili Z; Isaacs TW; Bentel J; Reid AL; Dwarkasing RS; Pereira MR; Khattak MA; Meniawy TM; Millward M; Brosens E; de Klein A; Chen FK; Kiliҫ E; Gray ES
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14953-14963. PubMed ID: 37608028
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity and molecular landscape of melanoma: implications for targeted therapy.
Beigi YZ; Lanjanian H; Fayazi R; Salimi M; Hoseyni BHM; Noroozizadeh MH; Masoudi-Nejad A
Mol Biomed; 2024 May; 5(1):17. PubMed ID: 38724687
[TBL] [Abstract][Full Text] [Related]
16. Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.
Versluis M; de Lange MJ; van Pelt SI; Ruivenkamp CA; Kroes WG; Cao J; Jager MJ; Luyten GP; van der Velden PA
PLoS One; 2015; 10(3):e0116371. PubMed ID: 25764247
[TBL] [Abstract][Full Text] [Related]
17. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
Vandekerkhove G; Struss WJ; Annala M; Kallio HML; Khalaf D; Warner EW; Herberts C; Ritch E; Beja K; Loktionova Y; Hurtado-Coll A; Fazli L; So A; Black PC; Nykter M; Tammela T; Chi KN; Gleave ME; Wyatt AW
Eur Urol; 2019 Apr; 75(4):667-675. PubMed ID: 30638634
[TBL] [Abstract][Full Text] [Related]
18. Release of Cell-Free Tumor DNA in the Plasma of Uveal Melanoma Patients Under Radiotherapy.
Kim V; Guberina M; Bechrakis NE; Lohmann DR; Zeschnigk M; Le Guin CHD
Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):35. PubMed ID: 37862025
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
20. Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma.
Bidard FC; Madic J; Mariani P; Piperno-Neumann S; Rampanou A; Servois V; Cassoux N; Desjardins L; Milder M; Vaucher I; Pierga JY; Lebofsky R; Stern MH; Lantz O
Int J Cancer; 2014 Mar; 134(5):1207-13. PubMed ID: 23934701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
